Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherBASIC SCIENCE INVESTIGATIONS

Whole-Body Biodistribution and Radiation Dosimetry of 18F-GE067: A Radioligand for In Vivo Brain Amyloid Imaging

Michel Koole, Dewi M. Lewis, Christopher Buckley, Natalie Nelissen, Mathieu Vandenbulcke, David J. Brooks, Rik Vandenberghe and Koen Van Laere
Journal of Nuclear Medicine May 2009, 50 (5) 818-822; DOI: https://doi.org/10.2967/jnumed.108.060756
Michel Koole
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dewi M. Lewis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher Buckley
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natalie Nelissen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mathieu Vandenbulcke
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David J. Brooks
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rik Vandenberghe
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Koen Van Laere
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Data supplements

  • Supplemental Data

    Files in this Data Supplement:

    • Supplemental Table 1
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 50 (5)
Journal of Nuclear Medicine
Vol. 50, Issue 5
May 2009
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Supplemental Data
  • Supplemental Data
  • Supplemental Data
  • Supplemental Data
  • Supplemental Data
  • Supplemental Data
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Whole-Body Biodistribution and Radiation Dosimetry of 18F-GE067: A Radioligand for In Vivo Brain Amyloid Imaging
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Whole-Body Biodistribution and Radiation Dosimetry of 18F-GE067: A Radioligand for In Vivo Brain Amyloid Imaging
Michel Koole, Dewi M. Lewis, Christopher Buckley, Natalie Nelissen, Mathieu Vandenbulcke, David J. Brooks, Rik Vandenberghe, Koen Van Laere
Journal of Nuclear Medicine May 2009, 50 (5) 818-822; DOI: 10.2967/jnumed.108.060756

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Whole-Body Biodistribution and Radiation Dosimetry of 18F-GE067: A Radioligand for In Vivo Brain Amyloid Imaging
Michel Koole, Dewi M. Lewis, Christopher Buckley, Natalie Nelissen, Mathieu Vandenbulcke, David J. Brooks, Rik Vandenberghe, Koen Van Laere
Journal of Nuclear Medicine May 2009, 50 (5) 818-822; DOI: 10.2967/jnumed.108.060756
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Association of Enlarged Perivascular Spaces and Measures of Small Vessel and Alzheimer Disease
  • An Overview of PET Radiochemistry, Part 1: The Covalent Labels 18F, 11C, and 13N
  • Whole-Body Biodistribution and Dosimetry of the Dopamine Transporter Radioligand 18F-FE-PE2I in Human Subjects
  • Increased midlife triglycerides predict brain {beta}-amyloid and tau pathology 20 years later
  • SNMMI Procedure Standard/EANM Practice Guideline for Amyloid PET Imaging of the Brain 1.0
  • Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease
  • Performance Characteristics of Amyloid PET with Florbetapir F 18 in Patients with Alzheimer's Disease and Cognitively Normal Subjects
  • 18F-ML-10, a PET Tracer for Apoptosis: First Human Study
  • In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand 18F-AV-45 (Flobetapir F 18)
  • Phase 1 Study of the Pittsburgh Compound B Derivative 18F-Flutemetamol in Healthy Volunteers and Patients with Probable Alzheimer Disease
  • Google Scholar

More in this TOC Section

  • 11C-Methionine PET of Myocardial Inflammation in a Rat Model of Experimental Autoimmune Myocarditis
  • Counting Rate Characteristics and Image Distortion in Preclinical PET Imaging During Radiopharmaceutical Therapy
  • Design and Fabrication of Kidney Phantoms for Internal Radiation Dosimetry Using 3D Printing Technology
Show more Basic Science Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire